Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-25-004757
Filing Date
2025-04-14
Accepted
2025-04-14 12:32:26
Documents
7
Period of Report
2025-04-14

Document Format Files

Seq Description Document Type Size
1 6-K gmab-20250414x6k.htm 6-K 23158
2 EX-99.1 gmab-20250414xex99d1.htm EX-99.1 66358
3 EX-99.1(A) gmab-20250414xex99d1a.htm EX-99.1(A) 21744444
4 EX-99.1(B) gmab-20250414xex99d1b.htm EX-99.1(B) 16587260
5 GRAPHIC gmab-20250414xex99d1001.jpg GRAPHIC 4880
6 GRAPHIC gmab-20250414xex99d1a001.jpg GRAPHIC 4617
7 GRAPHIC gmab-20250414xex99d1b001.jpg GRAPHIC 4617
  Complete submission text file 0001558370-25-004757.txt   38442082
Mailing Address TOLDBODGADE 33 1253 COPENHAGEN K G7 00000
Business Address TOLDBODGADE 33 1253 COPENHAGEN K G7 00000
GENMAB A/S (Filer) CIK: 0001434265 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38976 | Film No.: 25834942
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)